+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Growth Opportunities in Microbiome Therapeutics, AI-Enabled Diagnostics, Advanced Wound Healing, DNA Storage, Single Cell Analysis, and Multi-Omics Platforms

  • PDF Icon


  • 55 Pages
  • December 2021
  • Region: Global
  • Frost & Sullivan
  • ID: 5574924

The IntelligentIA Platform Combines Immune System, RNA Sequencing, and Machine Learning Ability

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) presents growth opportunities in microbiome therapeutics, AI-enabled diagnostics, advanced wound healing, DNA storage, single cell analysis, and multi-omics platforms.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Table of Contents

  1. Innovations in Life Sciences, Health & Wellness
  2. IntelligentIA Platform for Early Prostate Cancer Diagnosis
  3. The IntelligentIA Platform Combines Immune System, RNA Sequencing, and Machine Learning Ability
  4. Immunis.AI - Investor Dashboard
  5. DNA Data Storage for Research, Data Archival, and Product Tagging
  6. Helixworks’ Enzymatic DNA Synthesis Could Serve Future Data Storage
  7. Helixworks - Investor Dashboard
  8. Cloud-based Solutions for the Cancer Diagnosis and Monitoring
  9. C2I Genomics’ Platform Predicts Cancer from a 2 ml Blood Sample Months Earlier Than Conventional Diagnosis
  10. C2I Genomics - Investor Dashboard
  11. Automated Single-Cell Proteomics Analysis
  12. Highly Multiplexed Proteomics Within One System
  13. Isoplexis Corporation - Investor Dashboard
  14. Probiotic Solution for Infant Gut Microbiome Balance
  15. Restoring Deficient Bacteria in Infants
  16. Evolve Biosystems - Investor Dashboard
  17. Advanced Ai Augmented Single-Cell Multi-Omics Platform
  18. Single-Cell Analysis Solutions for Genotypic and Phenotypic Analysis
  19. Mission Bio - Investor Dashboard
  20. Defined Microbial Consortia for CDI Infection
  21. Bacterial Consortia Against CDI Colonization
  22. Vedanta Biosciences - Investor Dashboard
  23. Engineered Microbial Therapeutics for Phenylketonuria
  24. Efficacy Comparable to Small Molecule Drugs
  25. Synlogic - Investor Lens
  26. Fecal Microbiota Transplantation Product for CDI
  27. Rich Pipeline of Candidates for GI Conditions and Beyond
  28. Finch Therapeutics - Investor Dashboard
  29. Tapping the Gut Musculoskeletal Axis for Inflammatory Diseases
  30. Mine Novel Microbial Strains for Inflammatory Conditions
  31. Solarea Bio - Investor Dashboard
  32. Developing Cellulose-based Hemostatic Dressing
  33. Instant Self-Wound Management Solution
  34. Chitotech - Investor Dashboard
  35. Developing Novel RNA Interference Therapeutics and Delivery
  36. Building Efficient Ligand-Mediated Delivery for RNA Drug Delivery
  37. Arrowhead Pharmaceuticals - Investor Dashboard
  38. Developing Novel Next Generation Protein Therapeutics
  39. Entering a New Era of Programmable Proteins
  40. Generate Biomedicines - Investor Dashboard
  41. Ai Integrated Molecular Diagnostics for Lung Cancer
  42. Assessing Minute Changes in Non-Small Cell Lung Cancer
  43. Biodesix - Investor Dashboard
  44. Ai Platform for De Novo Drug Design and Development
  45. Multi-Dimensional Use of Ai Platform in Drug Discovery
  46. Xtalpi - Investor Dashboard
  47. Key Contacts

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Arrowhead Pharmaceuticals
  • Biodesix
  • C2I Genomics
  • Chitotech
  • Evolve Biosystems
  • Finch Therapeutics
  • Generate Biomedicines
  • Helixworks
  • Immunis.AI
  • Isoplexis Corporation
  • Mission Bio
  • Solarea Bio
  • Vedanta Biosciences
  • Xtalpi